Sheejan Yuliya

Sheejan Yuliya

Active Director Director DIN 09367524
DIN 09367524 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Sheejan Yuliya

Data last updated:

Sheejan Yuliya is a Director at Astrazeon Pharma Private Limited (since 2021). The company operates in Chemicals. Astrazeon Pharma Private Limited reported revenue of ₹19.1 Lakh (FY 2024).

DIN 09367524
Primary Designation Director
Industry Chemicals
First Appointment 21 Oct 2021
Oldest Company Age 5 yrs
Largest company Astrazeon Pharma Private Limited · ₹19.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Astrazeon Pharma Private Limited U24299KL2021PTC071698
Director21 Oct 20212021₹19.1 Lakh (FY 2024)Active

Board colleagues of Sheejan Yuliya

Directorship timeline

Open interactive timeline →
Astrazeon Pharma Private Limited
Premium access

Shareholding and investment profile for Sheejan Yuliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheejan Yuliya

Sheejan Yuliya currently holds 1 directorship: Astrazeon Pharma Private Limited (Director, since 21 Oct 2021, revenue ₹19.1 Lakh (FY 2024)).

Sheejan Yuliya was first appointed on 21 Oct 2021 as Director at Astrazeon Pharma Private Limited.

The current boards of Sheejan Yuliya's companies include Ajesh Vasantha Kumar (Astrazeon Pharma Private Limited), Benny Purandaran Vasanthamani (Astrazeon Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available